The impact of primary diseases is substantial, demanding groundbreaking therapeutic strategies. Cellular therapies represent a particularly exciting avenue, offering the chance to regenerate damaged hepatic tissue and improve patient outcomes. Currently, research focuses on several techniques, including the delivery of induced pluripotent cellular